Global Asset & Launch Leader for Emerging Biopharma

IQVIA Inc

New York (NY)

On-site

USD 169,000 - 470,000

Full time

4 days ago
Be an early applicant

A complete application in a minute

Tailored resume and cover letter, ready to send.

Get past ATS filters

Job summary

IQVIA is seeking a Global Asset Partner to lead senior client relationships with Emerging Biopharma in the US, guiding asset development through commercialization and lifecycle growth. You will act as a trusted advisor to CEOs and C-suite leaders, shaping strategies and mobilizing IQVIA's capabilities across evidence, market access, medical affairs, and launch execution.

This role leverages deep commercialization expertise to navigate global launches, organizational readiness, and cross-region

Qualifications

  • 15+ years of experience in life sciences, global commercialization, or management consulting in senior client-facing roles.
  • Experience advising Emerging Biopharma companies.
  • Proven ability to build trusted relationships with CEOs and C-suite leaders.
  • Strong consultative selling capabilities with a track record of multi-service opportunities.
  • Experience managing near-term opportunities and multi-year strategic partnerships in matrixed orgs.
  • Excellent executive communication, strategic thinking, problem-solving and storytelling skills.
  • Experience working across multiple geographies and supporting global brands or programs.

Responsibilities

  • Build executive-level relationships with CEOs, founders and senior leaders across assigned accounts.
  • Advise clients on commercialization strategy, launch readiness, market access, evidence generation, and operating model design.
  • Connect IQVIA capabilities into integrated molecule-to-market solutions.
  • Drive revenue growth by expanding executive relationships and opportunities across regions.

Skills

Executive leadership
Life sciences
Global commercialization
Strategic partnerships
Sales / consultative selling
Executive communication

Job description

IQVIA is seeking a Global Asset Partner to lead senior client relationships with Emerging Biopharma in the US, guiding asset development through commercialization and lifecycle growth. You will act as a trusted advisor to CEOs and C-suite leaders, shaping strategies and mobilizing IQVIA's capabilities across evidence, market access, medical affairs, and launch execution.

This role leverages deep commercialization expertise to navigate global launches, organizational readiness, and cross-region

Get your free, confidential resume review.

or drag and drop your file here.

Similar jobs

Similar jobs worth comparing

Global Asset Strategy & Launch Partner
Global Asset Strategy & Launch Partner

IQVIA Inc • United States

Remote
USD 169,000 - 470,000
Senior Global Asset & Launch Commercialization Leader
Senior Global Asset & Launch Commercialization Leader

IQVIA Inc • Chicago (IL)

On-site
USD 169,000 - 470,000
Senior Global Asset & Launch Strategist
Senior Global Asset & Launch Strategist

IQVIA Inc • Durham (NC)

On-site
USD 169,000 - 470,000
Global Asset & Commercialization Leader
Global Asset & Commercialization Leader

NCBioImpact • Durham (NC)

On-site
USD 169,000 - 470,000
Global Asset & Commercialization Lead
Global Asset & Commercialization Lead

IQVIA • Wayne (PA)

On-site
USD 169,000 - 470,000
Global Asset Partner: Commercialization Leader
Global Asset Partner: Commercialization Leader

IQVIA Inc • New York (NY)

On-site
USD 169,000 - 470,000
Senior Global Asset & Commercialization Partner
Senior Global Asset & Commercialization Partner

IQVIA Inc • Marietta (GA)

On-site
USD 169,000 - 470,000
Global Asset & Commercialization Leader
Global Asset & Commercialization Leader

IQVIA Inc • Durham (NC)

On-site
USD 169,000 - 470,000
Strategic Global Commercialization Partner
Strategic Global Commercialization Partner

IQVIA Inc • Chicago (IL)

On-site
USD 169,000 - 470,000
Remote Global Asset & Commercialization Leader
Remote Global Asset & Commercialization Leader

Lifelancer • United States

Remote
USD 180,000 - 260,000